Jake Cason

Jake Cason has extensive work experience in various finance and operations roles. Jake is currently the Chief Financial Officer at Daniel Defense, LLC since 2023. Prior to this, they worked at Sorrento Therapeutics, Inc. where they held the positions of Head of Finance & Operations, Sofusa Lymphatic Drug Development from 2021 to 2023, Director of Finance & Business Operations, Sofusa Lymphatic Drug Development from 2019 to 2021, and Manager, Finance & Business Operations, Sofusa Lymphatic Drug Development from 2018 to 2019. Before their time at Sorrento Therapeutics, Inc., Jake worked at Kimberly-Clark as a Finance Lead, Corporate Innovation & HR (Global Functions) from 2017 to 2018 and as a Business Analyst in Global Supply Chain/Manufacturing & Logistics from 2016 to 2017. Jake also worked at Diversified Trust as Vice President, Investment Management & Family Office Services from 2013 to 2015 and held roles as Client Service Manager from 2011 to 2013 and Client Service Associate from 2008 to 2011.

Jake Cason pursued their education in a consistent and focused manner. In 2005, they began their academic journey at The University of Georgia, undertaking a Bachelor of Business Administration (BBA) degree in the field of Finance. Jake dedicated himself to their studies for two years, completing their undergraduate program in 2007.

Continuing their pursuit of knowledge, Jake then enrolled at Emory University's Goizueta Business School in 2010. Jake engaged in a rigorous program, dedicating three years to earn a Master of Business Administration (MBA) degree. Although the field of study for their MBA is unspecified, it can be inferred that it is related to business due to their background and the choice of school.

Overall, Jake's education history demonstrates a commitment to business education, starting with their undergraduate studies in finance and culminating in a specialized Master's degree in business administration.